標題：
1、Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
2、Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical
practice: results from the STRONG prospective, observational, multicenter study
3、Bioequivalence study of two perindopril erbumine tablet formulations in healthy volunteers
4、Development and in vitro/in vivo evaluation of immediate release perindopril tablets
5、The advantages of combination therapy on hypertension: development of immediate release perindoprilindapamide
tablet and assessment of bioequivalence studies
6、Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors? - PubMed - NCBI
7、Drug Dev Ind Pharm. 2013 Jul;39(7):996-1004. doi: 10.3109/03639045.2012.689765. Epub 2012 May 25.
A potent preparation method combining neutralization with microfluidization for rebamipide nanosuspensions and its in vivo evaluation.
Shi Y1, Zou M, An Y, Ji Z, Gao P, Cheng G.
8、Drug Dev Ind Pharm. 2006 Jul;32(6):651-60.
Production of an extremly low dose procaterol HCl preparation by fluidized-bed coating method: in vitro and in vivo evaluation.
Yu TW1, Chen RR, Gau CS.
9、Enhancement of solubility and dissolution of cilostazol by solid dispersion technique.
Park JH, Choi HK.
Arch Pharm Res. 2015 Jul;38(7):1336-44. doi: 10.1007/s12272-014-0547-6. Epub 2015 Jan 8.
10、Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form.
Xiong X, Xu K, Li S, Tang P, Xiao Y, Li H.
Drug Dev Ind Pharm. 2017 Feb;43(2):283-292. doi: 10.1080/03639045.2016.1239627. Epub 2016 Oct 6.
要求：將符合要求的文獻PDF格式打包上傳
[更多]
渝公網(wǎng)安備 50010802001068號
